On 9/1/2022 Sonia Arteaga filed an Application for Adjudication of Claim alleging injury, while employed by Starcrest Products of California, to hernia, excretory system, back, shoulders and multiple parts during the period of 6/7/2021 through 6/7/2022.
Arteaga began treating with Dr. Haghighinia, of Medland Medical, on 10/07/2022. The initial Request for Authorization was sent by Medland to Defendant, Zenith Insurance on 10/24/2022. Zenith did send notice of the intent to defer Utilization Review on a basis other than medical necessity to Medland on 10/24/2022.
Zenith denied the claim on 11/29/2022. Nonetheless Sonia Arteaga continued to treat with Medland subsequent to the denial.
On 10/12/2023 the case settled by Compromise and Release for for $35,000, with the Order Approving Compromise and Release.
A Notice and Request for Allowance of Lien was filed by Medland on 11/9/2023, followed by a Declaration of Readiness on 11/17/2023. The matter came before the WCJ for a lien trial on 5/1/2024. The matter was submitted on 5/1/2024 and a Findings and Order issued on 6/28/2024.
Among the findings, the WCJ found that Arteaga sustained injury AOE/COE, Zenith did not retain medical control through the MPN during the delay period, Zenith was liable for the Med-Legal services performed by Medland on 2/22/2023 and Zenith was permitted to conduct retrospective UR regarding dates of service 10/07/2022 through 8/28/2023 (excluding date of service 2/22/2023).
Medland filed a Petition for Reconsideration disputing only the finding that Defendant is permitted to conduct retrospective UR regarding dates of service 10/07/2022 through 8/28/2023 (excluding date of service 2/22/2023).
The WCAB panel denied reconsideration in the case of Arteaga v Starcrest Products of California -ADJ16637235 (October 2024)
In its Petition for Reconsideration the Lien claimant contends that the WCJ erred in deferring the issue of the medical treatment lien pending retrospective utilization review. Lien claimant argues that defendant waived its ability to conduct retrospective utilization review by not timely responding to each request for authorization.
California Code of Regulation §9792.9.1(b) governs the deferral of Utilization Review when there are threshold disputes other than medical necessity. CCR §9792.9.1(b)(1) indicates that “a written decision deferring utilization review of the requested treatment unless the requesting physician has been previously notified under this subdivision of a dispute over liability..”
Defendant did issue an Utilization Review deferral notice to the initial Request for Authorization from Medland dated 10/24/2022. That notice dated 10/24/2022 was timely issued (within five business days of the date of the Request for Authorization). At the time of all subsequent Requests for Authorization, Medland was already on notice that Defendant was disputing their request for treatment of the Applicant due to a threshold issue other than medical necessity.
In his report, the WCJ agreed with the rational in the panel case of Ghattas v. O’Reilly Auto Parts, Safety Nat’l Cas. Co., 2018 Cal. Wrk. Comp. P.D. LEXIS 86, which notes that Defendant is not required to submit Requests for Authorization to Utilization Review following a timely denial of the case.
The WCAB panel concluded by saying “Here, the WCJ correctly determined that defendant was entitled to retrospective utilization review. The WCJ found that the defendant responded to lien claimant’s first request for authorization with a timely and proper notice to defer utilization review on a basis other than medical necessity.”
“As noted above, Administrative Rule 9792.9.1(b)(1) exempts the defendant from having to issue subsequent delay notices to subsequent requests for authorization if ‘the requesting physician has been previously notified under this subdivision of a dispute over liability and an explanation for the deferral of utilization review for a specific course of treatment.’ Since defendant timely and properly advised the lien claimant of the liability dispute in response to the first request for authorization, it did not have an obligation to issue any subsequent delay notices.”